Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine

NCT04009824 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

NIH

Sponsor class

Conditions

Mosquito-Borne Infectious Diseases

Interventions

BIOLOGICAL: AGS-v PLUS Vaccine
BIOLOGICAL: Montanide ISA-51 Adjuvant
BIOLOGICAL: Alhydrogel® Adjuvant
BIOLOGICAL: Saline Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]